Comparative statistics by cancer registry

Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site

(Seoul, South Korea, 1993-1997 cases followed-up until 2001)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	Total included	Dead		Alive		Complete FU		Median FU (in months)
Site	ICD-10	Total included	No.	%	No.	%	No.	%	Median FU (in months)
C00	Lip	26	13	50.0	13	50.0	26	100.0	46.0
C01-02	Tongue	243	115	47.3	128	52.7	243	100.0	54.4
C03-06	Oral cavity	303	169	55.8	134	44.2	303	100.0	36.2
C07-08	Salivary gland	194	71	36.6	123	63.4	194	100.0	62.5
C09	Tonsil	92	47	51.1	45	48.9	92	100.0	52.4
C10	Other oropharynx	52	36	69.2	16	30.8	52	100.0	21.9
C11	Nasopharynx	278	164	59.0	114	41.0	278	100.0	40.4
C12-13	Hypopharynx	170	129	75.9	41	24.1	170	100.0	15.1
C15	Oesophagus	1134	947	83.5	187	16.5	1134	100.0	9.2
C16	Stomach	16180	9354	57.8	6826	42.2	16180	100.0	28.3
C17	Small intestine	242	172	71.1	70	28.9	242	100.0	15.6
C18	Colon	3720	1641	44.1	2079	55.9	3720	100.0	54.5
C19-20	Rectum	3715	1743	46.9	1972	53.1	3715	100.0	53.2
C21	Anus	313	233	74.4	80	25.6	313	100.0	16.2
C22	Liver	9872	8208	83.1	1664	16.9	9872	100.0	6.2
C23-24	Gall bladder	2293	1779	77.6	514	22.4	2293	100.0	9.1
C25	Pancreas	1807	1572	87.0	235	13.0	1807	100.0	4.8
C26	Gastrointestinal tract unspecified	58	47	81.0	11	19.0	58	100.0	4.6
C30-31	Nose/Sinuses	224	126	56.3	98	43.8	224	100.0	47.9
C32	Larynx	791	320	40.5	471	59.5	791	100.0	58.5
C33-34	Lung	8482	7166	84.5	1316	15.5	8482	100.0	8.3
C37-38	Other thoracic organs	226	122	54.0	104	46.0	226	100.0	34.0
C40-41	Bone	343	186	54.2	157	45.8	343	100.0	44.9
C43	Melanoma skin	179	96	53.6	83	46.4	179	100.0	50.6
C44	Other skin	618	131	21.2	487	78.8	618	100.0	68.7
C45	Mesothelioma	52	33	63.5	19	36.5	52	100.0	23.4
C47+C49	Connective tissue	484	228	47.1	256	52.9	484	100.0	53.7
C48	Peritoneum	160	102	63.8	58	36.3	160	100.0	28.3
C50	Breast	5355	1298	24.2	4057	75.8	5355	100.0	66.5
C51	Vulva	55	22	40.0	33	60.0	55	100.0	52.8
C52	Vagina	46	16	34.8	30	65.2	46	100.0	65.8
C53	Cervix	5357	1342	25.1	4015	74.9	5357	100.0	67.5
C54	Corpus uteri	522	99	19.0	423	81.0	522	100.0	72.2
C55	Uterus unspecified	87	26	29.9	61	70.1	87	100.0	67.2
C56	Ovary	1305	483	37.0	822	63.0	1305	100.0	58.3
C57	Other female genital	85	51	60.0	34	40.0	85	100.0	22.9
C58	Placenta	113	8	7.1	105	92.9	113	100.0	81.5
C60	Penis	43	16	37.2	27	62.8	43	100.0	61.0
C61	Prostate	948	460	48.5	488	51.5	948	100.0	53.6
C62	Testis	106	11	10.4	95	89.6	106	100.0	75.9
C64	Kidney	1177	444	37.7	733	62.3	1177	100.0	59.4
C65	Renal pelvis	147	53	36.1	94	63.9	147	100.0	61.4
C66	Ureter	104	51	49.0	53	51.0	104	100.0	55.8
C67	Urinary bladder	1930	712	36.9	1218	63.1	1930	100.0	60.4
C68	Other urinary organs	64	42	65.6	22	34.4	64	100.0	19.3
C69	Eye	93	31	33.3	62	66.7	93	100.0	65.9
C70-72	Brain & nervous system	1163	721	62.0	442	38.0	1163	100.0	21.2
C73	Thyroid	2657	229	8.6	2428	91.4	2657	100.0	72.0
C74	Adrenal gland	87	54	62.1	33	37.9	87	100.0	32.7
C75	Other endocrine	78	29	37.2	49	62.8	78	100.0	60.6
C81	Hodgkin lymphoma	133	40	30.1	93	69.9	133	100.0	63.6
C82-85+C96	Non-Hodgkin lymphoma	1680	799	47.6	881	52.4	1680	100.0	52.7
C90	Multiple myeloma	347	257	74.1	90	25.9	347	100.0	24.1
C91	Lymphoid leukaemia	595	352	59.2	243	40.8	595	100.0	27.6
C92-94	Myeloid leukaemia	1219	915	75.1	304	24.9	1219	100.0	13.6
C95	Leukaemia unspecified	80	68	85.0	12	15.0	80	100.0	5.7

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Seoul, South Korea, 1993-1997 cases followed-up until 2001)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Seoul, South Korea, 1993-1997 cases followed-up until 2001)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Seoul, South Korea, 1993-1997 cases followed-up until 2001)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Seoul, South Korea, 1993-1997 cases followed-up until 2001)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)

Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

Comparative statistics by cancer registry

Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site